Morgan Stanley’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.5M Sell
661,518
-241,364
-27% -$4.91M ﹤0.01% 3164
2025
Q1
$16.4M Sell
902,882
-441,217
-33% -$8.01M ﹤0.01% 2892
2024
Q4
$34M Buy
1,344,099
+908,281
+208% +$23M ﹤0.01% 2218
2024
Q3
$14.8M Buy
435,818
+271,826
+166% +$9.24M ﹤0.01% 3093
2024
Q2
$6.07M Sell
163,992
-212,129
-56% -$7.85M ﹤0.01% 3737
2024
Q1
$15.8M Sell
376,121
-940,609
-71% -$39.5M ﹤0.01% 2946
2023
Q4
$52.2M Buy
1,316,730
+793,030
+151% +$31.5M ﹤0.01% 2403
2023
Q3
$14.4M Buy
523,700
+385,916
+280% +$10.6M ﹤0.01% 2783
2023
Q2
$4.68M Sell
137,784
-355,261
-72% -$12.1M ﹤0.01% 3823
2023
Q1
$17.7M Buy
493,045
+289,356
+142% +$10.4M ﹤0.01% 2560
2022
Q4
$9.08M Buy
203,689
+306
+0.2% +$13.6K ﹤0.01% 3183
2022
Q3
$5.72M Sell
203,383
-278,644
-58% -$7.84M ﹤0.01% 3565
2022
Q2
$13M Sell
482,027
-536,997
-53% -$14.5M ﹤0.01% 2781
2022
Q1
$34.7M Buy
1,019,024
+713,091
+233% +$24.3M ﹤0.01% 1568
2021
Q4
$11.8M Buy
305,933
+128,397
+72% +$4.96M ﹤0.01% 2761
2021
Q3
$9.58M Buy
177,536
+54,377
+44% +$2.94M ﹤0.01% 2939
2021
Q2
$4.12M Buy
123,159
+101,154
+460% +$3.38M ﹤0.01% 3983
2021
Q1
$453K Buy
22,005
+2,459
+13% +$50.6K ﹤0.01% 5206
2020
Q4
$343K Buy
19,546
+3,667
+23% +$64.4K ﹤0.01% 5290
2020
Q3
$236K Sell
15,879
-7,263
-31% -$108K ﹤0.01% 5023
2020
Q2
$301K Buy
23,142
+3,639
+19% +$47.3K ﹤0.01% 4878
2020
Q1
$33K Sell
19,503
-1,667
-8% -$2.82K ﹤0.01% 5616
2019
Q4
$48K Buy
21,170
+11,724
+124% +$26.6K ﹤0.01% 5869
2019
Q3
$20K Sell
9,446
-1,686
-15% -$3.57K ﹤0.01% 6014
2019
Q2
$30K Buy
11,132
+8,774
+372% +$23.6K ﹤0.01% 5802
2019
Q1
$11K Sell
2,358
-3,411
-59% -$15.9K ﹤0.01% 6152
2018
Q4
$17K Buy
5,769
+2,956
+105% +$8.71K ﹤0.01% 6045
2018
Q3
$20K Sell
2,813
-31,157
-92% -$222K ﹤0.01% 6131
2018
Q2
$256K Sell
33,970
-2,440
-7% -$18.4K ﹤0.01% 5449
2018
Q1
$1.27M Buy
36,410
+7,505
+26% +$262K ﹤0.01% 4377
2017
Q4
$1.23M Sell
28,905
-7,038
-20% -$300K ﹤0.01% 4405
2017
Q3
$1.54M Buy
35,943
+3,483
+11% +$149K ﹤0.01% 4107
2017
Q2
$1.2M Sell
32,460
-1,434
-4% -$53.1K ﹤0.01% 4238
2017
Q1
$1.84M Sell
33,894
-12,099
-26% -$655K ﹤0.01% 3883
2016
Q4
$2.44M Sell
45,993
-1,845
-4% -$98K ﹤0.01% 3756
2016
Q3
$2.9M Buy
47,838
+8,910
+23% +$540K ﹤0.01% 3183
2016
Q2
$2.56M Buy
38,928
+1,522
+4% +$100K ﹤0.01% 3215
2016
Q1
$2.12M Sell
37,406
-16,218
-30% -$920K ﹤0.01% 3302
2015
Q4
$12.6M Buy
53,624
+121
+0.2% +$28.5K ﹤0.01% 1778
2015
Q3
$8.46M Sell
53,503
-4,123
-7% -$652K ﹤0.01% 2133
2015
Q2
$21.8M Buy
57,626
+675
+1% +$255K 0.01% 1421
2015
Q1
$23.8M Sell
56,951
-3,700
-6% -$1.55M 0.01% 1319
2014
Q4
$16.6M Buy
60,651
+8,896
+17% +$2.44M 0.01% 1613
2014
Q3
$10.1M Sell
51,755
-4,865
-9% -$946K ﹤0.01% 2007
2014
Q2
$13.9M Buy
56,620
+6,836
+14% +$1.67M 0.01% 1739
2014
Q1
$13.2M Buy
49,784
+7,080
+17% +$1.88M 0.01% 1732
2013
Q4
$15.5M Buy
42,704
+5,347
+14% +$1.94M 0.01% 1564
2013
Q3
$19.9M Buy
37,357
+1,652
+5% +$878K 0.01% 1235
2013
Q2
$8.36M Buy
+35,705
New +$8.36M ﹤0.01% 1840